Tesla
TSLA
MicroStrategy
MSTR
MARA Holdings
MARA
Apple
AAPL
Microsoft
MSFT
US Stock MarketDetailed Quotes
APGE Apogee Therapeutics
- 44.500
- +0.180+0.41%
Close Dec 13 16:00 ET
- 44.990
- +0.490+1.10%
Post 20:02 ET
2.60BMarket Cap-17.26P/E (TTM)
45.320High41.850Low692.23KVolume44.140Open44.320Pre Close30.12MTurnover2.38%Turnover RatioLossP/E (Static)58.51MShares72.29052wk High3.55P/B1.30BFloat Cap22.20052wk Low--Dividend TTM29.13MShs Float72.290Historical High--Div YieldTTM7.83%Amplitude14.190Historical Low43.511Avg Price1Lot Size
Apogee Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -113.90%-42.52M | -101.10%-29.3M | -199.67%-31.64M | -355.11%-74.76M | -223.80%-29.75M | -19.88M | -14.57M | -10.56M | -16.43M | -9.19M |
| Net income from continuing operations | -135.21%-49.02M | -79.06%-33.82M | -156.24%-32.09M | -111.10%-83.99M | -126.57%-31.74M | ---20.84M | ---18.89M | ---12.53M | ---39.79M | ---14.01M |
| Depreciation and amortization | --48K | --36K | --29K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Other non cash items | --387K | --280K | --266K | -99.24%87K | ---- | ---- | ---- | ---- | --11.4M | --563K |
| Change In working capital | 1,290.10%3.73M | -51.84%1.54M | -289.19%-1.31M | -37.80%6.11M | 19.36%2.52M | ---313K | --3.2M | --694K | --9.82M | --2.11M |
| -Change in prepaid assets | -95.34%-2.81M | 36.82%-1.21M | -3,222.73%-1.46M | -1,587.88%-2.79M | 473.94%617K | ---1.44M | ---1.92M | ---44K | ---165K | ---165K |
| -Change in payables and accrued expense | 505.24%6.81M | -40.14%3.07M | -44.17%412K | -7.14%9.27M | 0.18%2.28M | --1.13M | --5.12M | --738K | --9.98M | --2.28M |
| -Change in other current assets | ---46K | ---- | ---- | ---107K | ---107K | --0 | ---- | ---- | --0 | ---- |
| -Change in other current liabilities | ---229K | ---244K | ---263K | ---270K | ---270K | --0 | --0 | --0 | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -113.90%-42.52M | -101.10%-29.3M | -199.67%-31.64M | -355.11%-74.76M | -223.80%-29.75M | ---19.88M | ---14.57M | ---10.56M | ---16.43M | ---9.19M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 37.50%-146.38M | -148.71M | -51.74M | -273.91M | -39.69M | -234.22M | 0 | 0 | 0 | 0 |
| Net PPE purchase and sale | ---751K | ---51K | ---351K | ---167K | ---167K | --0 | --0 | --0 | --0 | ---- |
| Net investment purchase and sale | 37.82%-145.63M | ---148.66M | ---51.39M | ---273.74M | ---39.53M | ---234.22M | --0 | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 37.50%-146.38M | ---148.71M | ---51.74M | ---273.91M | ---39.69M | ---234.22M | --0 | --0 | --0 | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.88%383K | 91.15%-150K | 450.52M | 87.38%315.39M | -100.13%-213K | 317.3M | -1.69M | 0 | 168.32M | 158.5M |
| Net common stock issuance | --0 | ---541K | --450.5M | --315.39M | 97.83%-213K | --315.6M | --0 | --0 | --0 | ---9.82M |
| Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --168.32M | ---- |
| Proceeds from stock option exercised by employees | --383K | --391K | --24K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.88%383K | 91.15%-150K | --450.52M | 87.38%315.39M | -100.13%-213K | --317.3M | ---1.69M | --0 | --168.32M | --158.5M |
| Net cash flow | ||||||||||
| Beginning cash position | 145.94%307.59M | 243.69%485.75M | -21.91%118.61M | --151.89M | 7,188.77%188.27M | --125.07M | --141.33M | --151.89M | --0 | --2.58M |
| Current changes in cash | -398.29%-188.52M | -995.41%-178.16M | 3,577.70%367.14M | -121.91%-33.28M | -146.65%-69.66M | --63.2M | ---16.26M | ---10.56M | --151.89M | --149.31M |
| End cash Position | -36.75%119.07M | 145.94%307.59M | 243.69%485.75M | -21.91%118.61M | -21.91%118.61M | --188.27M | --125.07M | --141.33M | --151.89M | --151.89M |
| Free cash flow | -117.68%-43.28M | -101.45%-29.35M | -202.99%-31.99M | -356.13%-74.93M | -225.62%-29.92M | ---19.88M | ---14.57M | ---10.56M | ---16.43M | ---9.19M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.